[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR017984A1 - Proceso para formar una composicion farmaceutica de topiramato y composicion farmaceutica de topiramato - Google Patents

Proceso para formar una composicion farmaceutica de topiramato y composicion farmaceutica de topiramato

Info

Publication number
AR017984A1
AR017984A1 ARP990100895A ARP990100895A AR017984A1 AR 017984 A1 AR017984 A1 AR 017984A1 AR P990100895 A ARP990100895 A AR P990100895A AR P990100895 A ARP990100895 A AR P990100895A AR 017984 A1 AR017984 A1 AR 017984A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
topiramato
core particles
topiramate
particles
Prior art date
Application number
ARP990100895A
Other languages
English (en)
Spanish (es)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22134079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR017984(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR017984A1 publication Critical patent/AR017984A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP990100895A 1998-03-04 1999-03-03 Proceso para formar una composicion farmaceutica de topiramato y composicion farmaceutica de topiramato AR017984A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7677098P 1998-03-04 1998-03-04

Publications (1)

Publication Number Publication Date
AR017984A1 true AR017984A1 (es) 2001-10-24

Family

ID=22134079

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP990100895A AR017984A1 (es) 1998-03-04 1999-03-03 Proceso para formar una composicion farmaceutica de topiramato y composicion farmaceutica de topiramato
ARP050101282A AR048457A2 (es) 1998-03-04 2005-03-31 Proceso para formar una composicion farmaceutica de topiramato
ARP050101281A AR048456A2 (es) 1998-03-04 2005-03-31 Composicion farmaceutica de topiramato

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP050101282A AR048457A2 (es) 1998-03-04 2005-03-31 Proceso para formar una composicion farmaceutica de topiramato
ARP050101281A AR048456A2 (es) 1998-03-04 2005-03-31 Composicion farmaceutica de topiramato

Country Status (32)

Country Link
US (4) US6696091B2 (fr)
EP (1) EP1066027B1 (fr)
JP (1) JP2003530295A (fr)
KR (1) KR20010041592A (fr)
CN (1) CN100364501C (fr)
AR (3) AR017984A1 (fr)
AT (1) ATE246490T1 (fr)
AU (1) AU763643B2 (fr)
BG (1) BG64885B1 (fr)
BR (1) BR9908488A (fr)
CA (1) CA2322644C (fr)
DE (1) DE69910186T2 (fr)
DK (1) DK1066027T3 (fr)
EA (1) EA200000814A1 (fr)
EE (1) EE04175B1 (fr)
ES (1) ES2204109T3 (fr)
HK (1) HK1032009A1 (fr)
HR (1) HRP20000563B1 (fr)
HU (1) HUP0301192A3 (fr)
ID (1) ID26982A (fr)
IL (2) IL138032A0 (fr)
MY (1) MY125821A (fr)
NO (1) NO20004311L (fr)
NZ (1) NZ506532A (fr)
PL (1) PL194559B1 (fr)
PT (1) PT1066027E (fr)
SK (1) SK285440B6 (fr)
TR (1) TR200002541T2 (fr)
TW (1) TW590778B (fr)
UA (1) UA65607C2 (fr)
WO (1) WO1999044581A2 (fr)
ZA (1) ZA991716B (fr)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099865A (en) * 1998-07-08 2000-08-08 Fmc Corporation Croscarmellose taste masking
NZ513724A (en) 1999-02-17 2004-01-30 Ortho Mcneil Pharm Inc Anticonvulsant derivatives useful in treating essential tremor
NZ514811A (en) * 1999-04-08 2005-01-28 Ortho Mcneil Pharm Inc Anticonvulsant derivatives useful in reducing blood glucose levels
AU770068B2 (en) * 1999-06-14 2004-02-12 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
EP1157682A1 (fr) † 2000-05-25 2001-11-28 Cilag AG Emballage blister pour comprimés de topiramate
NZ523531A (en) 2000-07-07 2005-07-29 Ortho Mcneil Pharm Inc Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X
AU2002253838B2 (en) * 2000-10-30 2006-11-09 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising anti-diabetic and anticonvulsant agents
US7771749B2 (en) 2001-07-11 2010-08-10 Monsanto Technology Llc Lignin-based microparticles for the controlled release of agricultural actives
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) * 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
NZ537543A (en) * 2002-07-29 2007-08-31 Alza Corp Formulations and high dose osmotic dosage forms for controlled delivery of topiramate
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
TW200507884A (en) * 2002-12-13 2005-03-01 Cilag Ag Stable topiramate formulations
JP4469846B2 (ja) * 2003-01-31 2010-06-02 エラン ファーマ インターナショナル，リミティド ナノ粒子状トピラメート製剤
ITMI20031096A1 (it) * 2003-05-30 2004-11-30 Eurand Spa Microcapsule per coacervazione contenenti farmaco incorporato nel polimero di rivestimento
US6949518B1 (en) 2003-06-25 2005-09-27 Pao-Hsien Chu Methods for treating macular degeneration with topiramate
EP1673064A1 (fr) * 2003-08-28 2006-06-28 Sandoz AG Composition pharmaceutique contenant un anticonvulsivant dote d'un enrobage masquant le gout
CA2564227A1 (fr) * 2003-09-02 2005-03-10 Alza Corporation Compositions medicamenteuses et formes pharmaceutiques de topiramate
JP4808392B2 (ja) * 2003-09-04 2011-11-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 苦味を隠蔽する薬理組成物
AU2004296877A1 (en) * 2003-12-09 2005-06-23 Incyte Corporation Dosing methods for ss-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
JP2007517062A (ja) * 2003-12-29 2007-06-28 アルザ・コーポレーシヨン 機械的圧縮中に付着抵抗を与える薬物顆粒のコーティング
WO2005065648A2 (fr) * 2003-12-29 2005-07-21 Alza Corporation, Inc., Nouvelles preparations de medicaments et formes posologiques de topiramate
CA2551815A1 (fr) * 2003-12-29 2005-07-21 Alza Corporation Compositions medicamenteuses et formes pharmaceutiques
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
WO2006127184A1 (fr) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Procede de fabrication de derives de sulfamide
EP1907988B1 (fr) * 2005-06-20 2013-11-06 AuthentiForm Technologies, L.L.C. Systemes et procedes d'authentification de produit
US7874489B2 (en) * 2005-06-20 2011-01-25 Authentiform Technologies, Llc Product authentication
US8247018B2 (en) * 2005-06-20 2012-08-21 Authentiform Technologies, Llc Methods for quality control
CA2521272A1 (fr) * 2005-10-04 2007-04-04 Bernard Charles Sherman Capsules comprenant du topiramate
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
JP2009537635A (ja) 2006-05-19 2009-10-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 癲癇の処置のための共同−療法
WO2008027557A2 (fr) * 2006-08-31 2008-03-06 Spherics, Inc. Compositions à base de topiramate et méthodes permettant d'en augmenter la biodisponibilité
WO2008034040A1 (fr) * 2006-09-15 2008-03-20 Regents Of The University Of Minnesota Compositions de topiramate et procédés de leur utilisation
US20090239942A1 (en) * 2006-09-15 2009-09-24 Cloyd James C Topiramate Compositions and Methods of Making and Using the Same
JP5489719B2 (ja) 2006-11-17 2014-05-14 スパーナス ファーマシューティカルズ インコーポレイテッド トピラマートの徐放性配合物
US20080131501A1 (en) * 2006-12-04 2008-06-05 Supernus Pharmaceuticals, Inc. Enhanced immediate release formulations of topiramate
US8895061B2 (en) * 2007-03-02 2014-11-25 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
KR20090122489A (ko) * 2007-03-26 2009-11-30 데이코쿠 세이야쿠 가부시키가이샤 결장-특이적 전달을 위한 경구적 약제학적 제제
JP5424571B2 (ja) * 2007-04-12 2014-02-26 協和発酵キリン株式会社 トピラマート含有固形製剤
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
PE20110060A1 (es) 2008-06-23 2011-01-31 Janssen Pharmaceutica Nv Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
JP6133009B2 (ja) * 2010-08-11 2017-05-24 協和発酵キリン株式会社 トピラマート顆粒
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
CN103316026B (zh) 2012-03-23 2016-05-11 中国人民解放军军事医学科学院毒物药物研究所 含芬特明和托吡酯的联合产品及其制备方法
CN102579367B (zh) * 2012-03-23 2014-03-12 中国人民解放军军事医学科学院毒物药物研究所 托吡酯缓释药物组合物、其制备方法及用途
WO2013139292A1 (fr) * 2012-03-23 2013-09-26 中国人民解放军军事医学科学院毒物药物研究所 Produit d'association contenant de la synéphrine et du topiramate
EP2915098A4 (fr) 2012-10-30 2016-07-06 Certirx Corp Authentification de produits, d'images ou de documents, vérification, et identification d'articles
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｐｅｄｉａｔｒｉｃｅｐｉｌｅｓｙａｎｄｅｐｉｌｅｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅｓ｝
US8652527B1 (en) * 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
CA2906172C (fr) 2013-03-15 2021-12-21 Aprecia Pharmaceuticals Company Forme posologique a dispersion rapide de topiramate
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
WO2014167439A1 (fr) * 2013-03-26 2014-10-16 Wockhardt Limited Compositions pharmaceutiques à libération modifiée de topiramate ou de sels de celui-ci
US20160128943A1 (en) * 2013-06-04 2016-05-12 KVK-Tech, Inc. Controlled release caffeine dosage forms
CN104922075A (zh) * 2015-05-31 2015-09-23 黑龙江佰彤儿童药物研究有限公司 一种治疗儿童癫痫的固体制剂及其制备方法
US20170312223A1 (en) * 2016-05-02 2017-11-02 Sun Pharmaceutical Industries Limited Sprinkle Composition of Cinacalcet
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
BR112018072539A2 (pt) 2016-05-05 2019-03-26 Aquestive Therapeutics, Inc. composições de epinefrina de administração aumentada
EP3883546A1 (fr) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Formulations de suspension de topiramate orale présentant une stabilité de conservation prolongée et une biodisponibilité améliorée

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
DD146547A5 (de) 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
US4205060A (en) 1978-12-20 1980-05-27 Pennwalt Corporation Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
DE3012136C2 (de) 1980-03-28 1984-02-16 Bauer, Kurt Heinz, Prof. Dr., 7800 Freiburg Verfahren zur Herstellung eines Granulats
JPS5758631A (en) * 1980-09-24 1982-04-08 Toyo Jozo Co Ltd Coating composition
EP0088635B1 (fr) * 1982-03-10 1986-12-30 Toray Industries, Inc. Film laminé et milieu d'enregistrement magnétique fabriqué avec ce film
US4994260A (en) 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
US4505616A (en) * 1983-05-26 1985-03-19 Litton Systems, Inc. Self-locking chock system for a jack-up rig unit
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4568559A (en) 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
GB8403361D0 (en) 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical composition
GB8403360D0 (en) 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
GB8403359D0 (en) 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
DE3405378A1 (de) 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
DE3440288C2 (de) 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
IT1183574B (it) 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US5286489A (en) 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
JPS63188621A (ja) 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
GB8702411D0 (en) 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
DK130287D0 (da) 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
FR2613619B1 (fr) 1987-04-07 1993-10-15 Recherche Informatique Pharmacie Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
US4994496A (en) 1987-09-09 1991-02-19 Repasky Elizabeth A Use of milk globules as carriers for drugs
US4851226A (en) 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
NZ226822A (en) * 1987-11-16 1990-03-27 Mcneil Consumer Prod Chewable medicament tablet containing means for taste masking
US4851266A (en) * 1988-05-31 1989-07-25 Akira Momose Surface treatment of powderfree surgical gloves
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
US4916161A (en) 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5013716A (en) 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
IT1227899B (it) 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US5275823A (en) 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5084278A (en) 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5417985A (en) 1989-07-20 1995-05-23 Farmalyoc Solid and porous single dosage form comprising particles in the form of beads and its preparation
JP3317444B2 (ja) * 1989-07-20 2002-08-26 大日本製薬株式会社 不快な味が遮蔽された速放性製剤
US5082669A (en) 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
NZ234587A (en) 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
DE3929166A1 (de) * 1989-09-02 1991-03-07 Basf Ag Verfahren zur herstellung magnetischer aufzeichnungstraeger
US4958252A (en) * 1990-01-16 1990-09-18 Westinghouse Electric Corp. Circuit breaker with rating plug having memory
US5206030A (en) 1990-02-26 1993-04-27 Fmc Corporation Film-forming composition and use for coating pharmaceuticals, foods and the like
IT1241417B (it) 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
FR2660317B1 (fr) 1990-03-27 1994-01-14 Seppic Produit filmogene destine a l'enrobage des formes solides; son procede de fabrication et produits revetus de ce produit.
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5460825A (en) 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2052679C (fr) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations et enrobages masquant les saveurs dans la preparation de comprimes pharmaceutiques a croquer
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2068402C (fr) 1991-06-14 1998-09-22 Michael R. Hoy Enrobage pour masquer le gout pouvant etre utilise dans des comprimes pharmaceutiques croquables
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
DE4201179A1 (de) 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
DE69331948T2 (de) 1992-06-04 2002-11-28 Smithkline Beecham Corp., King Of Prussia Angenehm schmeckende pharmazeutische zusammensetzungen
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CA2126685C (fr) 1992-10-26 2002-07-23 Bruno Gander Methode de preparation de microcapsules
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
US5354566A (en) 1993-06-02 1994-10-11 Kraft General Foods, Inc. Preparation of yeast-leavened dough crusts
EP0716597A1 (fr) 1993-08-30 1996-06-19 Warner-Lambert Company Enrobage de comprimes a base d'un melange file en fusion d'un saccharide et d'un polymere
US5425742A (en) * 1994-03-28 1995-06-20 Patrick S. Quigley Use of hollow hypobaric chambers on body parts for increasing blood flow, reducing pressure and decreasing pain
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
JPH0826977A (ja) * 1994-07-19 1996-01-30 Tanabe Seiyaku Co Ltd 溶出制御型経口製剤
US5705183A (en) 1994-11-16 1998-01-06 Phillips Company Cotton candy coated medication and a method for making and administering the same
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US5760007A (en) * 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain

Also Published As

Publication number Publication date
HUP0301192A3 (en) 2004-03-01
ID26982A (id) 2001-02-22
IL138032A0 (en) 2001-10-31
CN100364501C (zh) 2008-01-30
US20060286163A1 (en) 2006-12-21
HRP20000563B1 (en) 2009-07-31
HK1032009A1 (en) 2001-07-06
US20080260813A1 (en) 2008-10-23
BG64885B1 (bg) 2006-08-31
AR048457A2 (es) 2006-04-26
EE04175B1 (et) 2003-12-15
ATE246490T1 (de) 2003-08-15
JP2003530295A (ja) 2003-10-14
EP1066027B1 (fr) 2003-08-06
HRP20000563A2 (en) 2001-04-30
IL138032A (en) 2007-09-20
DE69910186T2 (de) 2004-07-29
NO20004311D0 (no) 2000-08-30
TR200002541T2 (tr) 2001-03-21
CN1419444A (zh) 2003-05-21
SK285440B6 (sk) 2007-01-04
HUP0301192A2 (hu) 2003-08-28
EP1066027A1 (fr) 2001-01-10
MY125821A (en) 2006-08-30
UA65607C2 (uk) 2004-04-15
PL194559B1 (pl) 2007-06-29
PL343894A1 (en) 2001-09-10
AU763643B2 (en) 2003-07-31
AR048456A2 (es) 2006-04-26
WO1999044581A2 (fr) 1999-09-10
TW590778B (en) 2004-06-11
PT1066027E (pt) 2003-12-31
DK1066027T3 (da) 2003-11-10
ES2204109T3 (es) 2004-04-16
US7125560B2 (en) 2006-10-24
US20020064563A1 (en) 2002-05-30
NZ506532A (en) 2003-08-29
US6696091B2 (en) 2004-02-24
CA2322644A1 (fr) 1999-09-10
BG104727A (en) 2001-05-31
EA200000814A1 (ru) 2001-02-26
AU2798999A (en) 1999-09-20
DE69910186D1 (de) 2003-09-11
KR20010041592A (ko) 2001-05-25
US20040156901A1 (en) 2004-08-12
CA2322644C (fr) 2005-07-26
NO20004311L (no) 2000-10-25
ZA991716B (en) 2000-10-11
WO1999044581A3 (fr) 2003-07-17
BR9908488A (pt) 2000-12-05
SK13062000A3 (sk) 2001-04-09
EE200000503A (et) 2002-02-15

Similar Documents

Publication Publication Date Title
AR017984A1 (es) Proceso para formar una composicion farmaceutica de topiramato y composicion farmaceutica de topiramato
AR015524A1 (es) FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO.
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
HUP0104039A2 (hu) Módosított hatóanyagleadású sokszemcsés készítmény
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
AR022930A2 (es) MICROCAPSULAS, DE TIPO RESERVORIO, QUE CONTIENEN POR LO MENOS UN PRINCIPIO ACTIVO MEDICAMENTOSO Y/O NUTRITIVO (PA) CON EXCLUSION DEL ACIDO ACETILSALICILICO (ASA), DESTINADAS A LA ADMINISTRACION POR VIA ORAL, SU UTILIZACIoN Y FORMA FARMACEUTICA QUE COMPRENDE A DICHAS MICROCAPSULAS.
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
AR065970A2 (es) Una composicion farmaceutica oral solida que comprende una combinacion de metformin y glibenclamida y uso de dicha composicion
RU99118587A (ru) Новый препарат для ингаляции, имеющий насыпную объемную плотность от 0,28 до 0,38 г/мл, способ его получения и его применение
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
ATE20518T1 (de) Trockene pulverige allergenzusammensetzung und verfahren zu deren herstellung.
NO20030897L (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
YU46705B (sh) Postupak za proizvodnju matrice za ispuštanje i/ili doziranje doziranje lekovite aktivne materije
EE04038B1 (et) Inhaleeritav formoterooli sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, meetod selle valmistamiseks ning kasutamine
BR0115989A (pt) Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
HUP0204202A2 (hu) Ibuprofent tartalmazó hatóanyag-preparátum, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
EA201170784A1 (ru) Гранулы тамсулозина для фиксированной комбинации
JP2594576B2 (ja) 持続性放出フッ化物組成物
EE9900293A (et) Uus inhaleeritav terbutaliinsulfaati sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, selle valmistamise protsess ja kasutamine
CN1208351A (zh) 含薯蓣皂苷配基的组合物
TR200101928T2 (tr) Geliştirilmiş kararlılığa sahip bileşimler

Legal Events

Date Code Title Description
FC Refusal